• 1.

    Neuen BL, et al.. Kidney Watch 2019: SGLT2 inhibitors and cardiorenal outcomes. ASN Kidney News 2019; 11:1415. https://www.asn-online.org/publications/kidneynews/archives/2019/KN_2019_02_feb.pdf

    • Search Google Scholar
    • Export Citation
  • 2.

    Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2020; 98:S1S115. doi: 10.1016/j.kint.2020.06.019

    • Search Google Scholar
    • Export Citation
  • 3.

    Packer M, et al.. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020; 383:14131424. doi: 10.1056/NEJMoa2022190

  • 4.

    Cannon CP, et al.. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med 2020; 383:14251435. doi: 10.1056/NEJMoa2004967

  • 5.

    Heerspink HJL, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020; 383:14361446. doi: 10.1056/NEJMoa2024816

  • 6.

    Bhatt DL, et al.. Sotagliflozin in patients with diabetes and chronic kidney disease [published online ahead of print November 16, 2020]. N Engl J Med doi: 10.1056/NEJMoa2030186; https://www.nejm.org/doi/full/10.1056/NEJMoa2030186

    • Search Google Scholar
    • Export Citation
  • 7.

    Bakris GL, et al.. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes [published online ahead of print October 23, 2020]. N Engl J Med doi: 10.1056/NEJMoa2025845; https://www.nejm.org/doi/full/10.1056/NEJMoa2025845

    • Search Google Scholar
    • Export Citation

Diabetic Kidney Disease and Beyond

  • 1 Visual Abstracts by Michelle G.A. Lim
  • | 2 Michelle G.A. Lim, MBChB, MRCP, is a kidney transplant fellow at the Royal Infirmary of Edinburgh, UK. Edgar V. Lerma, MD, FASN, is Clinical Professor of Medicine at the University of Illinois at Chicago and serves as KDIGO Knowledge Translation Lead. He is also a member of the Bayer Pharma RENOVATE (RENal Outcomes improVement in diAbeTEs) Steering Committee.
Restricted access